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Abstract 
Chimeric constructs of glucose transporters GLUT2 and GLUT4 were transiently expressed in COS-7 cells in order to determine 
regions of the proteins responsible for their differences in activity and ligand binding. Exchange of the C-terminal tail (aa 479-509) of 
GLUT4 failed to affect glucose transport activity assayed at 1 mM glucose or ligand binding (cytochalasin B, IAPS-forskolin). In 
contrast, exchange of the C-terminal half of GLUT4 (aa 222-509) for that of GLUT2 markedly reduced ligand binding (K  a of 
cytochalasin B binding 1.88 _+ 0.2 ~M vs. 0.21 _+ 0.06 in the wild-type GLUT4), and moderately (25%) reduced glucose transport 
activity. These data support he conclusion that the domains determining differences in ligand binding between GLUT4 and GLUT2 are 
located in the C-terminal half of the glucose transporters. 
Keywords: Glucose transport; 3-[125I]Iodo-4-azidophenetylamido-7-O-succinyldeacetyl-forskolin; Insulin-regulated glucose transporter GLUT4; Cytocha- 
lasin B 
1. Introduct ion involved in the recognition and translocation of the hexose. 
The carrier proteins mediating facilitated diffusion of Employing photoreactive glucose derivatives and radiola- 
beled cytochalasin B, Holman and Rees have located the 
glucose (GLUT1-4) are inhibited by several structurally site of covalent labeling with glucose to helix 9, and that 
diverse agents, e.g., cytochalasin B [1], forskolin [2], or of cytochalasin B to the internal site of helix l0 [7]. 
methylxanthines [3]. These inhibitory ligands appear to 
Similarly, the site of covalent labeling with the photoreac- 
share binding sites on the glucose transporters with glu- rive forskolin derivative IAPS-forskolin was determined by 
cose, because their binding is inhibited by glucose in a labeling, partial proteolysis and fragment identification 
competitive manner [1,4-6]. The binding characteristics of with specific antisera. In these experiments, the site of 
inhibitory ligands have been used by several investigators covalent labeling of the GLUT4 was located between 
to identify domains of the glucose transporter which are 
helices 7 and 9 [8]. Other researchers have found labeling 
of helix 10, but have confirmed that only the C-terminal 
125 125 Abbreviations: [ I]IAPS-forskolin, 3-[ I]Iodo-4-azidophenetyl- half, and none of the first six helices, is labeled [9]. 
amido-7-O-succinyldeacetyl-forskolin; GLUT1, erythrocyte/brain-type The glucose transporter isoforms differ markedly in 
glucose transporter; GLUT2, liver-type glucose transporter; GLUT4, their affinity, i.e. their K m for hexoses [10-13], but also in 
adipocyte/muscle-type glucose transporter; PMSF, phenylmethyl- the Ka of the inhibitory ligands [6,13]. Of the known 
sulfonylfluoride; SDS-PAGE, sodium dodecylsulfate polyacrylamide g l isoforms, GLUT4 exhibits the lowest K m for 3-O-methyl- 
electrophoresis. 
* Corresponding author. Fax: +49 241 8888433; e-mail: glucose under equilibrium exchange conditions [10] and 
joost@rwth-aachen.de, the highest affinity for both cytochalasin B and forskolin 
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[6]. GLUT2 exhibits the highest K m for glucose and bated for 16 h at 37°C. Thereafter, the medium was 
3-O-methylglucose [10,12]; it binds cytochalasin B with exchanged for 7.5 ml 15% glycerol in HBS-buffer, and the 
low affinity [14], and fails to bind forskolin [6]. These cells were incubated for 3 min. The buffer was removed by 
parallel differences in the affinities for glucose and aspiration, and monolayers were washed twice with pre- 
forskolin appear to reflect structural differences that deter- warmed PBS (138 mM NaC1, 2.6 mM KC1, 10 mM 
mine important domains in the carrier proteins. Recently, Na2HPO 4, 1.8 mM KH2PO 4, pH 7.4). The cells were then 
chimeric constructs of human GLUT2/GLUT4 have been incubated with fresh culture medium in an atmosphere of 
expressed in Xenopus oocytes in order to identify the 5% CO 2 at 37°C for 48 h. 
regions in these transporters which are responsible for their 
different affinities to glucose [15]. Since this expression 2.3. Preparation of membrane fractions from transfected 
system does not provide sufficient amounts of transporter cells 
protein for assays of ligand binding, we have expressed the 
chimeric onstructs in COS-7 cells, and have assessed their The transfected cells were homogenized and fraction- 
transport activity as well as the binding of cytochalasin B ated as previously described [16] with a modification of a 
and IAPS-forskolin. The data indicate that the domains protocol previously employed in 3T3-LI cells [17]. 
determining the affinities of ligand binding are located in 
the C-terminal half of the carrier protein, and do therefore 2.4. Immunochemical detection of the glucose transporters 
support the previous conclusion that both ligands bind 
predominantly, if not exclusively, to this part of the glu- Immunochemical detection and quantitation of the con- 
cose transporter [7,8]. Furthermore, the data argue against structs was performed with antisera gainst dodekapeptides 
a role of the C-terminal tail in activity and ligand binding corresponding with the C-terminus of GLUT4 or the 
of the transporters. GLUT2, and the N-terminus of the GLUT4. Antisera 
against he GLUT4 were characterized by cross- immuno- 
precipitation and blotting, antisera against the GLUT2 
2. Materials and methods were characterized with human liver membranes. All elec- 
2.1. Construction of chimeric glucose transporter cDNA trophoresis and blotting procedures were performed as 
and expression vectors described previously [ 16]. 
Constructs were generated as described [15] by a PCR- 2.5. Reconstitution of glucose transport activity from mem- 
based cloning approach, sequenced and subcloned as brane fractions 
XbaI-SmaI fragments from pBluescript (GLUT4, 
GLUT4(1-82) /GLUT2(98-524) ,  GLUT2(1-  Glucose transport activity reconstituted into lecithin 
98)/GLUT4(82-509), GLUT4(1-222)/GLUT2(238-524)), liposomes was assayed as described previously [18] with 
as a SmaI-HindlII fragment from pGOV (GLUT4(1- minor modifications [19]. 
479)/GLUT2(497-524)), or as a BgllI fragment (GLUT2) 
from pSP64T [13] into the mammalian expression vector 2.6. Photolabeling of glucose transporters with 1251-IAPS- 
pCMV which harbors a SV40 origin, a cytomegalovirus forskolin 
promoter, and a polyadenylation site [16]. 
2.2. Transfection of COS- 7 cells IAPS-forskolin (3-[ 125 I]iodo-4-azidophenetylamido-7- 
O-succinyl-deacetyl-forskolin) was prepared as described 
Transfection of COS-7 cells with glucose transporter [9] and was stored in ethanol solution at -20°C. Photola- 
cDNA was performed by a modification of the previously beling was performed by a modification of a previously 
described procedure [16]. COS-7 cells were obtained from published procedure [8]. Samples of plasma membranes 
American Type Culture Collection (Rockville, USA, cat. (30 txg membrane protein) in 100 ~1 of Tris-buffer (20 
no.: CRL 1651) and were grown in Dulbecco's modified mM, pH 7.4) were incubated with [125I]IAPS-forskolin (2 
Eagle's medium (pH 7.4) containing 10% fetal calf serum, p~l, 0.4 txCi, final concentration 50 nM) for 30 min on ice. 
20 mM Hepes, and 2 mM glutamine. The cells were The samples were photolyzed by 6 flashes (setting on 1000 
harvested by trypsination 24 h before the transfection and Watt* s) with the high pressure mercury lamp of the 
were seeded onto 153 cm 2 culture dishes at a final density LIZZY photolysis flash (Raytest, Straubenhardt, Germany). 
of 6.25 × 105 cells/dish. Four hours before the transfec- The reaction was immediately quenched by addition of 10 
tion, 25 ml fresh culture medium was added to the mono- Ixl 10% [3-mercaptoethanol, and the samples were diluted 
layer. DNA (25 ~zg/plate) was co-precipitated with 125 with 1 ml of ice-cold Tris-buffer (20 raM). Membranes 
mM CaCI 2 in HBS-buffer (140 mM NaC1, 0.75 mM were separated by centrifugation in a refrigerated mi- 
Na2HPO 4, 25 mM Hepes, pH 7.1) for 15 min in a final crofuge (13500 rpm, 30 min), and the resulting pellets 
volume of 2.5 ml. The calcium phosphate-DNA suspen- were separated by SDS-PAGE (10% gels). The gels were 
sion was added to the monolayers, and cells were incu- dried and autoradiographed for 2-7 days. 
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2.7. Assay of  equilibrium cytochalasin B binding ~. . ,~  _ 
Cytochalasin B binding was determined by a modifica- GLUT4 
tion of the previously published method [20]. Samples of 
plasma membranes (20 ~g protein) in 200 ~l Tris-buffer 
(20 mM, pH 7.4) were incubated with 0.05 I~Ci [3H]cyto- 
chalasin B (NEN, spec. act. 9.8 Ci/mmol), 0.04 IxCi 
[14C]urea (Amersham, 56 mCi/mmol), and the desired 
concentrations of unlabeled cytochalasin B (1, 10, 100, "~- -  
1000 and 10000 nM) for 10 min on ice. Membranes were 2 /4  J '  
separated by centrifugation in a refrigerated microfuge 
(13500 rpm, 30 min). After removal of the supernatants, 
the tips of the tubes were cut off, and the pellets were 
solubilized in 0.5 ml tissue solubilizer (BTS-450, Beck- 
man, Munich, Germany). Bound and free radioactivity 
were determined in a water-compatible scintillation cock- 
tail (Ready Protein, Beckman). Values of the bound frac- 
tion were corrected for trapped buffer by subtraction of 4/2T 
counts from [14C]urea. K d values were determined graphi- 
cally as described previously [21,22]. " "" 
3. Results 
Four chimeric glucose transporters (Fig. 1) were con- 412t ,  " ~ ~ ~ ~ ~ ~  
structed by a PCR-based approach which introduced suit- 
able restriction sites into the regions to be fused. By this -- 
strategy, the C-terminal cytoplasmatic tail (GLUT4/2T), " " . " )  ¢ ) "- 
the C-terminal half (GLUT4/2L) or the frst helix includ- -- -- 
ing intra- and extracellular loops (GLUT2/4) of the 
GLUT2 were introduced into the GLUT4. In addition, the 
first helix of GLUT4 was introduced into GLUT2 
(GLUT4/2). 4/2 
All constructs were subcloned into the mammalian ex- 
pression vector pCMV and transiently expressed in COS-7 ( ) 
cells. As is illustrated in Fig. 2, immunoreactive trans- ~ _ _ ~ "**" 
porter protein was detected in membranes from cells trans- 
fected with each of the chimeric constructs or with the 
wild-types. No immunoreactivity was detected in cells "~- -  
transfected with the bland vector. All transporters migrated G L UT2 
as broad smears because of their heterogenous glycosyla- 
tion [16,23]. However, there were differences in their . - - - _  .. ~ f -  
electrophoretic mobilit ies: GLUT4,  GLUT4/2 ,  ,M,. a f ) ,,. -- -**,- 
GLUT4/2L and GLUT4/2T produced a similar spectrum -- -- 
of bands between 45 and 66 kDa, whereas the GLUT2 Fig. 1. Schematic presentation of chimeric glucose transporters te ted in 
the present study. Helical domains of GLUT4 are represented by open 
migrated as a somewhat sharper signal at 55 kDa with two symbols, helices of GLUT2 are shaded. Loop domains of GLUT2 are 
additional bands (29 and 34 kDa) probably generated by depicted by broken lines. Numbering ofthe predicted amino acids in the 
proteolysis. Similarly, the GLUT2/4 product appeared constructs: GLUT4, 1-509; GLUT2/4, GLUT2(1-98)/GLUT4(82-509); 
sensitive to proteolysis, since a major portion of it mi- GLUT4/2T, GLUT4(1-479)/GLUT2(497-524); GLUT2/2L, GLUT4(1- 
grated with an apparent molecular weight of 24-28 kDa 222)/GLUT2(238-524); GLUT4/2, GLUT4(1-82)/GLUT2(98-524); 
(Fig. 2). The subcellular distribution of the chimeric con- GLUT2, 1-524. 
structs and the wild-type appeared essentially identical 
with 50% of the transporters in the plasma membrane Fig. 3 illustrates a comparison of the reconstituted 
fraction, 40% in the high-density microsomal fraction, and glucose transport activities of wild-type and chimeric 
approx. 10% of the total recovered transporter found in a transporters. In order to correct for differences in the 
low-density microsomal fraction, expression, a normalization procedure was employed which 
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took advantage of the epitope-specific antisera against 
GLUT4 (N-terminus and C-terminus) and GLUT2 (C- 8 
terminus). Immunoblots of the membranes with these anti- 1> 
sera allowed a normalization of all constructs with either ~ ~' 
N- or C-terminus of the GLUT4; the expression of the _= o . . . .  ; 
wild-type GLUT2 was normalized by comparison with the = = 
constructs GLUT4/2T and GLUT4/2L. Transfection of ~" ® ,, L~: 
COS-7 cells with GLUT4 routinely produced a 4- to 8-fold § ~ ~ !l -r 
2 increase in the reconstituted glucose transport activity (Fig. ~9 / 3). The effect of the construct GLUT4/2T, in which the V '~ ~!i!~ I 
C-terminus was exchanged, was indistinguishable from 0 I I 
that of GLUT4. The exchange of the C-terminal half (in . ,~  ~t. .o °~ *~ 
GLUT4/ZL) produced a small (20-25%) but significant ^w" __  __  f~ 
reduction (P  < 0.05, paired t-test of 6 different ransfec- 
tions) of the glucose transport activity of the GLUT4. The 
wild-type GLUT2, in contrast, showed a much lower 
transport activity in the reconstitution assay than GLUT4; 2 
transfection of its cDNA produced only a 2.5-fold increase 1> 
in uptake rates. As is illustrated in the lower panel of Fig. ~ < ~ ~.5 
3, transfection with the construct GLUT2/4 failed to ~ ~ -r- II l i b   i ~ !!  increase the reconstituted glucose transport activity. Be- o ~ ~ ~' ,. 
cause of the partial degradation of the protein as observed ~, 0, 
in the immunoblots (see Fig. 2), this finding was not ~ =~ 
entirely unexpected. Surprisingly, the construct GLUT4/2 o 0.5 
also appeared to generate an inactive protein; reconstituted [-'-~---] | 
0 
97- ....... C9 "v 
.... i 
........... Fig. 3. Reconstituted glucose transport activity in membranes from 
.... COS-7 cells transfected with chimeric glucose transporter constructs. iiiiiiii~i~!i i !iill ! 
45- Samples of plasma membranes (60 /,~g)from COS-7 cells transfected 
45- ~ i with the indicated constructs were solubilized and reconstituted into 
28- 28"~S i the lecithin data liposomes were corrected as described, for minor Glucose diff rences uptake in rates theWere GLUT assayed,immuno_ and 
............. reactivity as determined with antisera gainst he N-terminus of GLUT4 
IPM PM HD PM HD LD PM HD LD PM HD LD and the C-terminus of GLUT2 and GLUT4. Upper and lower panel 
Co GLUT4 GLUT2/4 GLUT2 represent data from two separate series as means ± S.D. of three indepen- 
dent transfections. 
C kDa 
- : ± 97 . . . .  ~ 
66 - 
S 
~: ~ ; ~;; transport activity from cells transfected with this construct ;~ was not different from that of the controls. It should be 
45-  noted that this construct increased glucose transport activ- 
28 - ........ ........ ity in Xenopus oocytes [15]. 
In order to assay equilibrium [3H]cytochalasin B bind- 
PM HD PM HD LD PM HD LD PM HD LD ing, large-scale transfections were performed with GLUT4, 
Co GLUT4/2 GLUT4/2Loop GLUT412Tail 
GLUT4/2T and GLUT4/2L. The other chimeric con- 
Fig. 2. Immunochemical detection of chimeric glucose transporters tran- 
siently expressed in COS-7 cells. COS-7 cells were transfected with the structs were  tested in preliminary assays (at tracer cyto- 
indicated constructs and fractionated as described. Samples of membrane chalasin B concentration only), and no specific binding 
proteins (2.5 txg/lane (A) or 10 Ixg/lane (B, C)) were separated by exceeding that of control samples was detected. The assays 
SDS-PAGE and immunoblotted. For comparison, membranes from were  run at 5 different cytochalasin B concentrations, and 
adipocytes (IPM) were run in parallel. PM, plasma membranes; HD, Scatchard plots (Fig. 4) were evaluated by subtraction of 
high-density microsomes; LD, low-density microsomes. Co, transfection each data point of a control curve (transfection of bland 
with bland vector. Immunochemical detection was performed with anti- 
serum against he C-terminus of GLUT4 (panel A), GLUT2 (panel B), or vector) from the data of the constructs along radial axes.  
the N-terminus of GLUT4 (panel C). This subtraction generated linear plots (filled symbols) 
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which give both the K d of cytochalasin B binding and the A 
total number of sites. Fig. 4 illustrates a representative kDa 
experiment indicating that the affinity of cytochalasin B 97- ~ ~ 
binding was identical in the wild-type GLUT4 and the 66- ~ 
construct GLUT4/2T, whereas it was markedly reduced in 45- ~ l ~ i ~  
i A 0,1 -o -  Control ~ ~i~:~ 0,08 ~, ~ GLUT4 28- 
",~ .t GLUT4-Control Cyto.B - + - + + + + + 
0,06 - ~,, pCMV IPM GLUT4 GLUT4/2 GLUT412 GLUT2/4 
B/F k ~ Loop 
0,02 
o 2o0 , , .  
B (pmol/mg protein) ............... 
28 
e o,1~, CNo.B  + + + ÷ ÷ 
-o--  Control pCMV GLUT4 GLUT4/2 GLUT4/2 GLUT2 pCMV 
0,08 =, --O-- GLUT4/2T Tall Loop 
~O • GLUT4F2T-Control Fig. 5. Labeling of chimeric glucose transporters expressed in COS-7 
0,06 \. cells with IAPS-forskolin. Cells were transfected with the indicated 
B/F O .~"~ \"  \ constructs, and samples of plasma membranes containing equal amounts 
0,04 of protein (30 Ixg) were photolysed with IAPS-forskolin in the presence 
~O- - - .  or absence of cytochalasin B (25 p,M). Note that the membrane prepara- 
0,02 tions contained approx. 3-fold more GLUT4/2L than GLUT4 and 
"~o ~"~ GLUT4/2T. Data in the upper and lower panel were from two different 
0 ~° - I "~-~ I ~ - ~  series, each being representative for 3 independent transfections, pCMV, 
0 100 200 300 400 500 control transfections with bland vector; IPM, plasma membranes from 
B (prnol/mg protein) adipocytes. 
C 0,1 
---o- Control the construct GLUT4/2L. Identical results were obtained 
0,08 ---o- GLUT4/2L in 3 independent additional transfections (means + S.E. of 
GLUT4/2L-Control Kd: GLUT4, 0.21 -t- 0.06 IxM; GLUT4/2T, 0.18 -t- 0.04; 
0,06 GLUT4/2L, 1.88 -t- 0.2; n = 4). 
B/F In order to assess the binding of IAPS-forskolin to the 
0,04 " \~ constructs expressed in COS-7 cells, membranes were 
"..o"-~ photolysed with [125I]IAPS-forskolin in the presence or 
0,02 "-~. -~ 
"'~. ~ u  absence of excess cytochalasin B (25 txM). In all experi- 
0 _ - . . . . . . .  ments, equal amounts of protein were photolyzed, because 
100 2O0 300 the efficiency of the labeling is dependent on this parame- 
B (pmol/mg protein) ter. The abundance of the immunoreactive transporters (not 
shown) was identical except in membranes with Fig. 4. Binding of cytochalasin B to chimeric glucose transporters 
expressed in COS-7 cells. Samples of plasma membranes (20 ixg) from GLUT4/2L which contained only one third of the im- 
COS-7 cells transfected with the indicated constructs were incubated as munoreactivity detected in the samples with GLUT4. As is 
described with [3H]cytochalasin B and unlabeled ligand. Bound and free shown in Fig. 5, the photolabeled wild-type GLUT4 pro- 
tracer fractions were separated by centrifugation, and the data were duced the anticipated broad signal between 45 and 66 kDa. 
calculated and presented as Scatchard plots. In order to correct for A portion of this signal is generated by the constitutive non-specific binding and constitutive GLUT1, differences between trans- 
fections with constructs and bland vector were determined by subtraction GLUT1, as was demonstrated by transfection with bland 
along radial axes [21,22]; the resulting data points (filled symbols) were vector. Transfection with the construct GLUT4/2L pro- 
evaluated as linear Scatchard plots. A, GLUT4; B, GLUT4/2T; C, duced a similar incorporation of the photolabel. Thus, 
GLUT4/2L. Means+ S.E. of K d (4 independent transfection experi- when normalized per amount of transporter, the photola- 
ments): GLUT4, 0.21 + 0.06 IxM; GLUT4/2T, 0.18-t-0.04; GLUT4/2L, beling of GLUT4/2L appears lower than that of  the 
1.88 + 0.2). Means -1- S.E. of number of binding sites: GLUT4, 0.11 _+ 0.04 
nM/mg of protein; GLUT4/2T, 0.094-1- 0.02; GLUT4/2L, 0.08-t- 0.003; wild-type GLUT4 because of  its approx. 3-fold higher 
n=4). abundance in the photolabeled membranes. When cells 
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were transfected with GLUT4/2 and GLUT2/4, only the nearly abolished in this construct. We had anticipated 
constitutive glucose transporter was labeled (signal at 66 parallel changes of glucose transport activity and cyto- 
kDa). In a second series of transfections and labeling chalasin B binding, because we assumed the ligands to 
reactions, the GLUT4/2T was studied and compared with bind to domains responsible for the affinity to glucose, i.e., 
wild-type GLUT4 and GLUT2. As is shown in the lower the K m. Moreover, it was recently shown that the K m of 
panel of the figure, there was no difference in the signals the GLUT4/2L, as determined in Xenopus  oocytes, in- 
between GLUT4 and GLUT4/2T. In contrast, no specific deed approached that of the GLUT2 [15], indicating that 
signal was observed that corresponded with the GLUT2. In the C-terminal half of the glucose transporters determines 
summary, the data indicate that GLUT4 and GLUT4/2T the K m. At present, we can only speculate that the kinetic 
are labeled to a similar extent. In contrast, labeling is parameters (Km and Vma x) were altered in GLUT4/2L in 
significantly reduced, but still detectable, with GLUT4/2L. a way that their changes compensated ach other at 1 mM 
Transfected GLUT2, however, was not labeled to any glucose, and that only a minor difference to the GLUT4 
detectable extent, resulted (Vma x increase and K m increase in GLUT4/2L). 
Since higher glucose concentrations interfere with the re- 
constitution assay, we could not analyze the possible Vma x 
4. Discussion or  K m changes in our expression system. 
Two of the constructs (GLUT2/4 and GLUT4/2) in- 
The present data indicate that binding of inhibitory vestigated here appeared completely inactive, because no 
ligands cytochalasin B and forskolin to the GLUT4 is additional glucose transport activity nor any ligand binding 
markedly reduced, when the C-terminal half of the protein was detected in cells transfected with these constructs. 
is exchanged for that of the GLUT2. Since this construct Western blots indicated that degradation might be respon- 
(GLUT4/2L) was still capable of catalyzing the transport sible for the inactivity of the GLUT2/4, but showed no 
of glucose, the reduction in ligand binding does not appear abnormality of the GLUT4/2. Thus, we assume that the 
to reflect a non-specific onformational change that com- exchange of helix 1 introduced a structural alteration that 
pletely destroyed the functions of the protein. In contrast to affected the processing of the transporters in the COS-7 
the exchange of the whole C-terminal half of the protein, cells, and gave rise to premature proteolysis (GLUT2/4) 
the exchange of the C-terminal tail (construct GLUT4/2T) or improper folding (GLUT4/2). This problem appeared 
was without any detectable effect on either transport activ- to be specifically related to the expression of the constructs 
ity or ligand binding. Therefore, the data localize the sites in COS-cells, because GLUT4/2 was capable of transport- 
of high-affinity binding of cytochalasin B and forskolin ing glucose when expressed in Xenopus  oocytes [15]. 
into the C-terminal half of the transporter protein, but The finding that the C-terminal, cytoplasmatic tail (con- 
exclude the participation of its intracellular tail segment, struct GLUT4/2T) is not important for glucose transport 
This conclusion is in good agreement with previous evi- activity of the GLUT4 is in apparent contrast to a previous 
dence based on photolabeling and proteolytic leavage of report [29]. In that study, replacement of the C-terminal 
the labeled proteins [7,8]. Furthermore, two tryptophan tail of GLUTI with that of the GLUT2 conferred a 
residues in the C-terminal half of the GLUT1 (W388 and GLUT2-1ike glucose transport activity. Several possibili- 
W412) have previously been identified as putative contact ties have to be considered in order to explain this discrep- 
sites for glucose, cytochalasin B and forskolin [24-26]. ancy. Firstly, it cannot be excluded that the role of the 
Finally, when the two halves of the GLUT1 are expressed C-terminus for transport activity is different in GLUT1 and 
together as separate proteins in SF9 cells, only the C- GLUT4. Secondly, it should be noted that the present data 
terminal half is labeled with cytochalasin B and a photore- were obtained with a cell-free system, whereas those of 
active bismannose compound [27]. Taken together, these Katagiri et al. [29] were from intact cells. Finally, it has to 
data strongly suggest hat the binding sites of inhibitory be stated that we have assayed the glucose transport 
ligands are predominantly, if not exclusively, located in activity at a single glucose concentration (1 mM), and that 
the C-terminal half of the glucose transporter. It should be the alterations in K m and Vma x might have compensated 
noted, however, that two residues in the N-terminal half each other at that concentration. However, our data clearly 
(Y143 [23] and Q161 [28]), which appear necessary for the indicate that the C-terminal tail is not important for the 
full transport activity and cytochalasin B binding, have high-affinity binding of cytochalasin B or forskolin to the 
recently been identified. Thus, it cannot entirely be ex- GLUT4. 
cluded that there are additional contact sites in the N- 
terminal half which are not detected by a photolabeling 
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